Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Expression of IER3 in hepatocellular carcinoma: clinicopathology, prognosis, and potential regulatory pathways

10 Mar 2022

Abstract excerpt

Background: Immediate early response 3 (IER3) is correlated to the prognosis of several cancers, but the precise mechanisms underlying the regulation by IER3 of the occurrence and development of hepatocellular carcinoma (HCC) remain unknown. Methods: The expression level of IER3 was examined by using in-house immunohistochemistry (IHC), public gene chip, and public RNA-sequencing (RNA-seq). The standardized mean...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Hepatocellular Carcinoma Treatment and Prognosis
Share to HER2/EGFR in Cancer Research
Share to Liver physiology and pathology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35291486
DOI: 10.7717/peerj.12944

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Expression of IER3 in hepatocellular carcinoma: clinicopathology, prognosis, and potential regulatory pathwaysPMID 35291486Read ↗

TNNI3 expression and prognostic value and correlation with tumor-infiltrating immune cells in LIHC: A bioinformatics analysisSemantic proximity Read ↗

Expressional and prognostic value of CRLF3 in liver hepatocellular carcinoma patients via integrated bioinformatics analyses and experimentsSemantic proximity Read ↗

ERCC3 serves as a prognostic biomarker for hepatocellular carcinoma and positively regulates cell proliferation and migrationSemantic proximity Read ↗

Establishment of a Prognostic Model Using Immune-Related Genes in Patients With Hepatocellular CarcinomaSemantic proximity Read ↗

TMEM88, CCL14 and CLEC3B as prognostic biomarkers for prognosis and palindromia of human hepatocellular carcinomaSemantic proximity Read ↗

CFHR3 is a potential novel biomarker for hepatocellular carcinoma.Semantic proximity Read ↗

Epigenic Regulated CENPA and IQGAP3 Identified as Ideal Early-Stage Hepatocellular Carcinoma MarkersSemantic proximity Read ↗

Identification and Validation of an Immune-Related eRNA Prognostic Signature for Hepatocellular CarcinomaSemantic proximity Read ↗

Increased Expression Together with the Gene Regulation Network of NEIL3 Predicts Poor Prognosis and Correlates with Immune Infiltrates in Hepatocellular CarcinomaSemantic proximity Read ↗

A novel circular RNA circ-LRIG3 facilitates the malignant progression of hepatocellular carcinoma by modulating the EZH2/STAT3 signalingSemantic proximity Read ↗

Comprehensive analysis of potential prognostic genes for the construction of a competing endogenous RNA regulatory network in hepatocellular carcinomaSemantic proximity Read ↗

A novel circular RNA circ-LRIG3 facilitates the malignant progression of hepatocellular carcinoma by modulating the EZH2/STAT3 signalingSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.